Havelock NC 超重临床试验
17项针对 超重的研究正在 Havelock及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- West Clinical Research, Morehead City · 距离 15 英里
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- West Clinical Research, Morehead City · 距离 15 英里
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Centricity Research - Morehead city /ID# 283264, Morehead City · 距离 15 英里
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- West Clinical Research, Morehead City · 距离 15 英里
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Lucas Research, Inc, Morehead City · 距离 15 英里
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- Carteret Medical Group, Morehead City · 距离 15 英里
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- West Clinical Research, Morehead City · 距离 15 英里
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Lucas Research, Inc, Morehead City · 距离 15 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Morehead City · 距离 15 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Morehead City · 距离 15 英里
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Centricity Research Morehead City Multispeciality, Morehead City · 距离 15 英里
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Lucas Research, Inc., Morehead City · 距离 15 英里
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Morehead City · 距离 15 英里
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Lucas Research, Inc, Morehead City · 距离 15 英里
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
招募中3 期
- Kailera Clinical Site, Morehead City · 距离 15 英里
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
招募中3 期
- Kailera Clinical Site, Morehead City · 距离 15 英里
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
招募中3 期
- Centricity Research Morehead City Specialty, Morehead City · 距离 15 英里
其他城市的 超重试验
- San Antonio, TX34 项研究
- Houston, TX33 项研究
- Chicago, IL29 项研究
- Orlando, FL27 项研究
- Las Vegas, NV23 项研究
- Miami, FL23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Havelock的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。